Ladenburg Thalmann Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3.8M	Buy	51,472 +9,536	+23%	+$825K	0.02%	586
2019 Q3	$3.2M	Sell	41,936 -6,424	-13%	-$534K	0.02%	626
2019 Q2	$4.24M	Sell	48,360 -10,110	-17%	-$862K	0.03%	503
2019 Q1	$5.29M	Buy	58,470 +13,674	+31%	+$1.16M	0.04%	420
2018 Q4	$3.21M	Sell	44,796 -47,576	-52%	-$3.83M	0.03%	506
2018 Q3	$8.86M	Buy	92,372 +11,467	+14%	+$1.11M	0.07%	235
2018 Q2	$7.1M	Hold	80,905	–	–	0.07%	266
2018 Q1	$7.1M	Sell	80,905 -13,607	-14%	-$1.24M	0.07%	266
2017 Q4	$8.02M	Buy	94,512 +38,416	+68%	+$3.22M	0.08%	246
2017 Q3	$4.86M	Buy	56,096 +28,216	+101%	+$2.26M	0.05%	316
2017 Q2	$2.15M	Buy	27,880 +4,971	+22%	+$353K	0.03%	566
2017 Q1	$1.59M	Sell	22,909 -156,787	-87%	-$10.5M	0.02%	669
2016 Q4	$10.6M	Sell	179,696 -42,566	-19%	-$2.63M	0.15%	143
2016 Q3	$14.7M	Buy	222,262 +548	+0.2%	+$33.9K	0.22%	104
2016 Q2	$12M	Buy	221,714 +4,647	+2%	+$255K	0.19%	117
2016 Q1	$11.2M	Buy	217,067 +163,480	+305%	+$8.49M	0.2%	117
2015 Q4	$3.76M	Sell	53,587 -3,182	-6%	-$217K	0.07%	255
2015 Q3	$3.53M	Buy	56,769 +249	+0.4%	+$19.6K	0.07%	258
2015 Q2	$4.75M	Sell	56,520 -3,378	-6%	-$263K	0.09%	212
2015 Q1	$4.5M	Buy	59,898 +11,727	+24%	+$819K	0.09%	225
2014 Q4	$2.99M	Buy	48,171 +45,306	+1,581%	+$2.58M	0.07%	272
2014 Q3	$149K	Sell	2,865 -747	-21%	-$38.1K	﹤0.01%	1372
2014 Q2	$185K	Sell	3,612 -7,278	-67%	-$328K	0.01%	1238
2014 Q1	$517K	Buy	10,890 +6,393	+142%	+$327K	0.02%	716
2013 Q4	$195K	Sell	4,497 -315	-7%	-$13K	0.01%	1093
2013 Q3	$207K	Sell	4,812 -297	-6%	-$12K	0.01%	999
2013 Q2	$178K	Buy	+5,109	New	+$180K	0.01%	1029

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Ladenburg Thalmann Financial Services's XBI Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 23% in Q4 2019, buying an estimated $825K and bringing the position to 51,472 shares worth $3.8M. The position accounts for 0.02% of the portfolio, ranked #586.

Ladenburg Thalmann Financial Services first reported a position in XBI in Q2 2013 and has held it in 27 quarters since. The position peaked at $14.7M in Q3 2016. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

Ladenburg Thalmann Financial Services held 51,472 shares of State Street SPDR S&P Biotech ETF worth $3.8M as of Q4 2019.
Ladenburg Thalmann Financial Services bought 9,536 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $825K.
State Street SPDR S&P Biotech ETF made up 0.02% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #586 holding.
Ladenburg Thalmann Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 27 quarters since.
Ladenburg Thalmann Financial Services's State Street SPDR S&P Biotech ETF position peaked at $14.7M in Q3 2016.
474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.